Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Total ReCord is a biotechnology company focused on developing a scalable platform for DNA-based data storage. Co-founded by genomics pioneer George Church, the company leverages synthetic biology to encode digital information into DNA sequences, offering a high-density, long-term, and sustainable alternative to traditional silicon-based storage. Total ReCord's technology aims to optimize the writing and reading processes of DNA data, targeting the massive growth in global data storage requirements. The company operates at the intersection of information technology and molecular biology to provide archival storage solutions with extreme longevity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Total ReCord.